October 5, 2007Agreement • October 10th, 2007 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This letter of agreement (the “Agreement”) sets forth the understanding and agreement by and between Friedli Corporate Finance, Inc., a Belize corporation (“FCF”), and Osiris Therapeutics, Inc., a Delaware corporation (“Osiris”), with regard to the commitment on the part of FCF to purchase or to cause others to purchase (FCF or such other purchasers, individually, a “Purchaser” and collectively, the “Purchasers”), from time to time, up to $30,000,000 in the aggregate (the “Commitment”) of shares of common stock, par value $0.001 per share, of Osiris (“Common Stock”), or promissory notes of Osiris (“Notes”). To that end, and with the intention on the part of each party hereto that the other rely on undertakings, agreements and commitments of the other hereunder, FCF and Osiris do agree as follows:
